The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Foznol 1000 mg Chewable Tablets



PCO Manufacturing Ltd.PPA0465/495/001

Main Information

Trade NameFoznol 1000 mg Chewable Tablets
Active SubstancesLanthanum
Dosage FormChewable tablet
Licence HolderPCO Manufacturing Ltd.
Licence NumberPPA0465/495/001

Group Information

ATC CodeV03AE Drugs for treatment of hyperkalemia and hyperphosphatemia
V03AE03 lanthanum carbonate

Status

License statusAuthorised
Licence Issued30/09/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back